share_log

阿里健康:股東週年大會通告

ALI HEALTH: NOTICE OF ANNUAL GENERAL MEETING

Hong Kong Stock Exchange ·  Jul 30 05:37
Summary by Moomoo AI
阿里健康信息技術有限公司將於2024年8月30日在杭州舉行股東週年大會,會議將審議包括審核2023年度財務報表、董事會報告及核數師報告在內的多項議程。會上將進行董事重選,包括徐海鵬先生為非執行董事,以及黃一緋女士、邵蓉博士和吳亦泓女士為獨立非執行董事。此外,將授權董事會釐定董事薪酬,並續聘安永會計師事務所為核數師。特別事項包括考慮通過股份發行及購回的普通決議案,以及批准2024年股份獎勵計劃和終止2014年股份獎勵計劃。會議還將討論公司細則的建議修訂。所有決議案將以投票表決方式進行,並於會後公布結果。
阿里健康信息技術有限公司將於2024年8月30日在杭州舉行股東週年大會,會議將審議包括審核2023年度財務報表、董事會報告及核數師報告在內的多項議程。會上將進行董事重選,包括徐海鵬先生為非執行董事,以及黃一緋女士、邵蓉博士和吳亦泓女士為獨立非執行董事。此外,將授權董事會釐定董事薪酬,並續聘安永會計師事務所為核數師。特別事項包括考慮通過股份發行及購回的普通決議案,以及批准2024年股份獎勵計劃和終止2014年股份獎勵計劃。會議還將討論公司細則的建議修訂。所有決議案將以投票表決方式進行,並於會後公布結果。
Alibaba Health Information Technology Co., Ltd. will hold its annual shareholder meeting on August 30, 2024 in Hangzhou. The meeting will review multiple agenda items, including the review of the 2023 financial statements, board of director report, and auditor's report. The meeting will also include the reelection of directors, including Mr. Xu Haipeng as non-executive director, and Ms. Huang Yige, Dr. Shao Rong and Ms.Wu Yihong as independent non-executive directors. In addition, the board will be authorized to determine director compensation and to re-engage Ernst & Young as the auditor. Special items include considering the passage of ordinary resolutions for share issuance and repurchase, as well as approving the 2024 share incentive plan and terminating the 2014 share incentive plan. The meeting will also discuss the proposed amendments to the company's articles of association. All resolutions will be voted upon and the results will be announced after the meeting.
Alibaba Health Information Technology Co., Ltd. will hold its annual shareholder meeting on August 30, 2024 in Hangzhou. The meeting will review multiple agenda items, including the review of the 2023 financial statements, board of director report, and auditor's report. The meeting will also include the reelection of directors, including Mr. Xu Haipeng as non-executive director, and Ms. Huang Yige, Dr. Shao Rong and Ms.Wu Yihong as independent non-executive directors. In addition, the board will be authorized to determine director compensation and to re-engage Ernst & Young as the auditor. Special items include considering the passage of ordinary resolutions for share issuance and repurchase, as well as approving the 2024 share incentive plan and terminating the 2014 share incentive plan. The meeting will also discuss the proposed amendments to the company's articles of association. All resolutions will be voted upon and the results will be announced after the meeting.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more